Published date: 19 August 2019

Last edited date: 19 August 2019

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 4 October 2017

Contract summary

Industry

  • Influenza vaccines - 33651660

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£0

Procurement reference

CM_PHV_14_5433

Published date

19 August 2019

Closing date

4 October 2017

Contract start date

1 August 2018

Contract end date

31 July 2021

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision for a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. Deliveries will be required from 1 August 2018 to 31 July 2020 with an option to extend for up to an additional 24 months.

More information

Attachments

Award information

Awarded date

9 February 2018

Contract start date

1 August 2018

Contract end date

31 July 2020

Total value of contract

£0

This contract was awarded to 1 supplier.

AstraZeneca UK Ltd

Address

1 Francis Crick Avenue,
Cambridge
CB2 0AA

Reference

Companies House number: 03674842

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Lynne Nichols

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

lynne.nichols@dh.gsi.gov.uk